1. Cardiovascular outcomes and systemic anti‐inflammatory drugs in patients with severe psoriasis: 5‐year follow‐up of a Danish nationwide cohort. (10th October 2014) Authors: Ahlehoff, O.; Skov, L.; Gislason, G.; Gniadecki, R.; Iversen, L.; Bryld, L.E.; Lasthein, S.; Lindhardsen, J.; Kristensen, S.L.; Torp‐Pedersen, C.; Hansen, P.R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 6(2015:Jun.) Page Start: 1128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characteristics of patients receiving ustekinumab compared with secukinumab for treatment of moderate‐to‐severe plaque psoriasis – nationwide results from the DERMBIO registry. (29th March 2017) Authors: Egeberg, A.; Iversen, L.; Gniadecki, R.; Hvid, L.; Dam, T.N.; Bryld, L.E.; Skov, L. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 7(2017) Page Start: 1183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparison of long‐term drug survival and safety of biologic agents in patients with psoriasis vulgaris. (1st January 2015) Authors: Gniadecki, R.; Bang, B.; Bryld, L.E.; Iversen, L.; Lasthein, S.; Skov, L. Journal: British journal of dermatology Issue: Volume 172:Number 1(2015:Jan.) Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of long‐term drug survival and safety of biologic agents in patients with psoriasis vulgaris. (30th November 2014) Authors: Gniadecki, R.; Bang, B.; Bryld, L.E.; Iversen, L.; Lasthein, S.; Skov, L. Journal: British journal of dermatology Issue: Volume 172:Number 1(2015:Jan.) Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Do generalists and specialists agree on descriptive acne morphology?. (19th September 2011) Authors: Yazdanyar, S.; Bryld, L.E.; Heidenheim, M.; Jemec, G.B.E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 27:Number 1(2013:Jan.) Page Start: 116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Myocardial function and effects of biologic therapy in patients with severe psoriasis: a prospective echocardiographic study. (6th April 2015) Authors: Ahlehoff, O.; Hansen, P.R.; Gislason, G.H.; Frydland, M.; Bryld, L.E.; Elming, H.; Jemec, G.B.E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 5(2016:May) Page Start: 819 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prevalence and characterization of treatment‐refractory psoriasis and super‐responders to biologic treatment: a nationwide study. (12th April 2022) Authors: Loft, N.; Egeberg, A.; Rasmussen, M.K.; Bryld, L.E.; Nissen, C.V.; Dam, T.N.; Ajgeiy, K.K.; Iversen, L.; Skov, L. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 8(2022) Page Start: 1284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety, efficacy and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis. (1st February 2018) Authors: Egeberg, A.; Ottosen, M.B.; Gniadecki, R.; Broesby‐Olsen, S.; Dam, T.N.; Bryld, L.E.; Rasmussen, M.K.; Skov, L. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety, efficacy and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis. (9th January 2018) Authors: Egeberg, A.; Ottosen, M.B.; Gniadecki, R.; Broesby‐Olsen, S.; Dam, T.N.; Bryld, L.E.; Rasmussen, M.K.; Skov, L. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety, efficacy, and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis. (14th February 2018) Authors: Egeberg, A.; Ottosen, M.B.; Gniadecki, R.; Broesby‐Olsen, S.; Dam, T.N.; Bryld, L.E.; Rasmussen, M.K.; Skov, L. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: e163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗